Modern Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Buy
5,874
+2,432
+71% +$132K ﹤0.01% 945
2026
Q1
$213K Sell
3,442
-1,075
-24% -$86K ﹤0.01% 817
2025
Q4
$431K Buy
4,517
+1,360
+43% +$133K 0.01% 567
2025
Q3
$308K Sell
3,157
-368
-10% -$38.1K 0.01% 634
2025
Q2
$379K Buy
3,525
+551
+19% +$55.8K 0.01% 549
2025
Q1
$300K Buy
2,974
+218
+8% +$22K 0.01% 524
2024
Q4
$246K Buy
+2,756
New +$243K 0.01% 502

Other funds holding BSX

Modern Wealth Management's BSX Position: Q2 2026 in Review

Modern Wealth Management increased its Boston Scientific (BSX) stake by 71% in Q2 2026, buying an estimated $132K and bringing the position to 5,874 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #945.

Modern Wealth Management first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $431K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Modern Wealth Management held 5,874 shares of Boston Scientific worth $251K as of Q2 2026.
  • Modern Wealth Management bought 2,432 Boston Scientific shares in Q2 2026, an estimated $132K.
  • Boston Scientific made up ﹤0.01% of Modern Wealth Management's portfolio in Q2 2026, its #945 holding.
  • Modern Wealth Management first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Modern Wealth Management's Boston Scientific position peaked at $431K in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Modern Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.